Chemomab Therapeutics Ltd... (CMMB)
NASDAQ: CMMB
· Real-Time Price · USD
1.42
0.05 (3.65%)
At close: May 02, 2025, 3:45 PM
1.40
-1.40%
After-hours: May 02, 2025, 04:15 PM EDT
Chemomab Therapeutics Revenue
Chemomab Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2024, Chemomab Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
20
Market Cap
1.34M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|